DIFFERENTIAL AND COMBINATORIAL MECHANISM OF ACTION OF GOLIMUMAB AND GUSELKUMAB IN ULCERATIVE COLITIS INDUCTION THERAPY: IL-23 BLOCKADE DRIVES RESTORATION OF NORMAL EPITHELIUM AND MUCOSAL HEALING

Prerak Desai  ¹     Patrick Branigan  ¹     Dylan Richards  ¹     Marion Vetter  ¹     Daniel Cua  ¹     Thomas Freeman  ^1    
1 Janssen Research & Development, LLC, Spring House

Topic
IBD, Immunology, Nurses

Session
Understanding the biology of therapeutic response in IBD

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)